Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Under DOJ’s Microscope: Teva Is Latest Company To Face Government Probe

Executive Summary

AstraZeneca, Merck, Novartis and Sanofi are also under investigation for potential health care fraud.

You may also be interested in...



Novo Probe By U.S. Expands To Insulin Manufacturing

Massachusetts U.S. Attorney’s office, which is also investigating firm’s marketing, now subpoenas Novo Nordisk for documents relating to potential issues at its plant in Kalundborg, Denmark.

Sunshine Data Could Fast-Track False Claims Act Cases – U.S. Prosecutors

Sunshine Act penalties are relatively small but the payment disclosures could provide ammo and shortcuts for investigations into the more costly False Claims Act cases, U.S. attorneys say. On the flip side, disclosure may lead to better behavior.

Teva False Claims Settlement Stems From Kickbacks To Single Doctor

Teva reaches $27.6 million settlement with Department of Justice and the state of Illinois over prescriptions for generic clozapine; deal comes as Ivax subsidiary is in final year of five-year corporate integrity agreement.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel